Rainbow (Biotechnology) Overview

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.51M

  • Investors
  • 13

Rainbow (Biotechnology) General Information

Description

Developer of an autologous bone marrow mesenchymal stem cell product designed to treat cerebral infarction. The company's product is directly administered to the area around cerebral infarction, enabling clinicians with regenerative medicine to treat neurological and vascular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, HX, HokkaidoKita Ward, Sapporo CityKita 21-jo Nishi 11-chome
  • Hokkaido University Food & Medical Innovation International Center, Kita-ku
  • Sapporo, Kita-ku 001-0021
  • Japan
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 1st Floor, HX, HokkaidoKita Ward, Sapporo CityKita 21-jo Nishi 11-chome
  • Hokkaido University Food & Medical Innovation International Center, Kita-ku
  • Sapporo, Kita-ku 001-0021
  • Japan

Rainbow (Biotechnology) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rainbow (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 29-May-2026 $1.51M Completed Generating Revenue
5. Early Stage VC 29-Sep-2023 Completed Generating Revenue
4. Accelerator/Incubator 17-Nov-2020 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A) 26-Oct-2020 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - Phase 1
1. Corporate 01-Nov-2018 Completed Clinical Trials - Phase 1
To view Rainbow (Biotechnology)’s complete valuation and funding history, request access »

Rainbow (Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Preferred
B Preferred
A preferred 200 $4743.01 $4743.01 1x $4743.01 11.45%
To view Rainbow (Biotechnology)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rainbow (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rainbow (Biotechnology) Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
AKK (Japan) Venture Capital Minority
Crypton Future Media Inc. Corporation Minority
Higin Capital Investment Bank Minority
Medical System Network Corporation Minority
S&S (Japan) Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Rainbow (Biotechnology) FAQs

  • Where is Rainbow (Biotechnology) headquartered?

    Rainbow (Biotechnology) is headquartered in Sapporo, Japan.

  • What is the size of Rainbow (Biotechnology)?

    Rainbow (Biotechnology) has 8 total employees.

  • What industry is Rainbow (Biotechnology) in?

    Rainbow (Biotechnology)’s primary industry is Biotechnology.

  • Is Rainbow (Biotechnology) a private or public company?

    Rainbow (Biotechnology) is a Private company.

  • What is the current valuation of Rainbow (Biotechnology)?

    The current valuation of Rainbow (Biotechnology) is .

  • What is Rainbow (Biotechnology)’s current revenue?

    The current revenue for Rainbow (Biotechnology) is .

  • How much funding has Rainbow (Biotechnology) raised over time?

    Rainbow (Biotechnology) has raised $4.75M.

  • Who are Rainbow (Biotechnology)’s investors?

    AKK (Japan), Crypton Future Media Inc., Higin Capital, Medical System Network, and S&S (Japan) are 5 of 13 investors who have invested in Rainbow (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process